Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.21, $0.06 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $232.5 million versus the consensus estimate of $221.5 million.

GUIDANCE:

Phibro Animal Health sees FY2023 EPS of $1.21-$1.31, versus the consensus of $1.27. Phibro Animal Health sees FY2023 revenue of $0.96-1 billion, versus the consensus of $0.98 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.